Serum Institute of India (SII) | Page 8 | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
June 25, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JUNE 25, 2025

Serum Institute of India (SII)

A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (COVID-19) in Pune, India, May 18, 2020. REUTERS/Euan Rocha
Coronavirus chronicle

India's Serum says made 40 million doses of AstraZeneca's Covid vaccine, to make Novavax shot soon

Serum declined to comment on whether the 40 million doses of the AstraZeneca vaccine were meant for global supply or only for India

Photo: NDTV
Coronavirus chronicle

Covid vaccine could be available by January-end, says SII CEO

FILE PHOTO: Men ride on a motorbike past a supply truck of India's Serum Institute, the world's largest maker of vaccines, which is working on a vaccine against the coronavirus disease (Covid-19) in Pune, India, May 18, 2020. REUTERS/Euan Rocha
Coronavirus chronicle

Serum Institute gets approval to resume Indian trial of AstraZeneca Covid vaccine: source

Adar Poonawalla, CEO of Serum Institute said it would take at least four to five years to produce enough Covid-19 vaccines. (Abhijit Bhatlekar/ Mint)
Coronavirus chronicle

Won’t be enough Covid-19 vaccines till 2024: Serum Institute of India CEO

FILE PHOTO: Men ride on a motorbike past a supply truck of India's Serum Institute, the world's largest maker of vaccines, which is working on a vaccine against the coronavirus disease (Covid-19) in Pune, India, May 18, 2020. REUTERS/Euan Rocha
Coronavirus chronicle

Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold

The urgent need for effective Covid-19 treatments and vaccines is causing a shift in drugmakers’ priorities. Photographer:  Andrey Rudakov/Bloomberg
Coronavirus chronicle

'Looking forward to the Covid-19 vaccine,' said CEO of Indian Serum Institute 

Photo:BSS/AFP
Coronavirus chronicle

Oxford vaccine : Phase 2 trial to begin today in India 

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net